Your browser doesn't support javascript.
loading
LAMP-5 is an essential inflammatory-signaling regulator and novel immunotherapy target for mixed lineage leukemia-rearranged acute leukemia.
Gracia-Maldonado, Gabriel; Clark, Jason; Burwinkel, Matthew; Greenslade, Brenay; Wunderlich, Mark; Salomonis, Nathan; Leone, Dario; Gatti, Evelina; Pierre, Philippe; Kumar, Ashish R; Lee, Lynn H.
Afiliação
  • Gracia-Maldonado G; Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, USA; Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati, Children's Hospital Medical Center, Cincinnati, OH, 45229.
  • Clark J; Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, USA; Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati, Children's Hospital Medical Center, Cincinnati, OH, 45229.
  • Burwinkel M; Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, USA; Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati, Children's Hospital Medical Center, Cincinnati, OH, 45229.
  • Greenslade B; Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, USA; Division of Oncology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229.
  • Wunderlich M; Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, USA; Division of Experimental Hematology and Cancer Biology, Cincinnati, Children's Hospital Medical Center, Cincinnati, OH, 45229.
  • Salomonis N; Division of Biomedical Informatics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229.
  • Leone D; Aix Marseille Université, CNRS, INSERM, Centre d'Immunologie de Marseille-Luminy (CIML), 13288 Marseille Cedex 9.
  • Gatti E; Aix Marseille Université, CNRS, INSERM, Centre d'Immunologie de Marseille-Luminy (CIML), 13288 Marseille Cedex 9.
  • Pierre P; Aix Marseille Université, CNRS, INSERM, Centre d'Immunologie de Marseille-Luminy (CIML), 13288 Marseille Cedex 9.
  • Kumar AR; Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, USA; Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati, Children's Hospital Medical Center, Cincinnati, OH, 45229, USA; Department of Pediatrics, University of Cincinnat
  • Lee LH; Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, USA; Division of Oncology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, USA.; Department of Pediatrics, University of Cincinnati School of Medicine, Cincinnati, OH, 452
Haematologica ; 107(4): 803-815, 2022 04 01.
Article em En | MEDLINE | ID: mdl-33910331
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Aguda Bifenotípica / Leucemia Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Haematologica Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Aguda Bifenotípica / Leucemia Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Haematologica Ano de publicação: 2022 Tipo de documento: Article